Tech Company Financing Transactions
ChemoCentryx Funding Round
Alta Partners, GIMV and HBM Healthcare Investments participated in a $29.8 million Series D funding round for ChemoCentryx. The funding round was announced by the company on 3/22/2007.
Transaction Overview
Company Name
Announced On
3/22/2007
Transaction Type
Venture Equity
Amount
$29,840,000
Round
Series D
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
850 Maude Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
ChemoCentryx develops orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Schall
Chief Financial Officer
Susan Kanaya
VP - Bus. Development
Markus Cappel
VP - Bus. Development
Dalia Rayes
VP - R & D
Rajinder Singh
Browse more venture capital transactions:
Prev: 3/22/2007: Quantance venture capital transaction
Next: 3/22/2007: Skylight Healthcare Systems venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs